nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfuzosin—KCNH2—Sunitinib—pancreatic cancer	0.194	0.474	CbGbCtD
Alfuzosin—CYP3A4—Tamoxifen—pancreatic cancer	0.0519	0.127	CbGbCtD
Alfuzosin—CYP3A4—Erlotinib—pancreatic cancer	0.0441	0.108	CbGbCtD
Alfuzosin—CYP3A4—Irinotecan—pancreatic cancer	0.0398	0.0971	CbGbCtD
Alfuzosin—CYP3A4—Docetaxel—pancreatic cancer	0.0292	0.0712	CbGbCtD
Alfuzosin—CYP3A4—Sunitinib—pancreatic cancer	0.0291	0.0709	CbGbCtD
Alfuzosin—CYP3A4—Doxorubicin—pancreatic cancer	0.0218	0.0531	CbGbCtD
Alfuzosin—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000847	0.00182	CcSEcCtD
Alfuzosin—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000846	0.00181	CcSEcCtD
Alfuzosin—Dizziness—Tamoxifen—pancreatic cancer	0.000845	0.00181	CcSEcCtD
Alfuzosin—Tachycardia—Fluorouracil—pancreatic cancer	0.000843	0.00181	CcSEcCtD
Alfuzosin—Hypotension—Irinotecan—pancreatic cancer	0.000843	0.00181	CcSEcCtD
Alfuzosin—Dizziness—Erlotinib—pancreatic cancer	0.000836	0.00179	CcSEcCtD
Alfuzosin—Hypotension—Gemcitabine—pancreatic cancer	0.000821	0.00176	CcSEcCtD
Alfuzosin—Eye disorder—Docetaxel—pancreatic cancer	0.00082	0.00176	CcSEcCtD
Alfuzosin—Flushing—Docetaxel—pancreatic cancer	0.000814	0.00175	CcSEcCtD
Alfuzosin—Cardiac disorder—Docetaxel—pancreatic cancer	0.000814	0.00175	CcSEcCtD
Alfuzosin—Vomiting—Tamoxifen—pancreatic cancer	0.000813	0.00174	CcSEcCtD
Alfuzosin—Hypotension—Fluorouracil—pancreatic cancer	0.000807	0.00173	CcSEcCtD
Alfuzosin—Rash—Tamoxifen—pancreatic cancer	0.000806	0.00173	CcSEcCtD
Alfuzosin—Dermatitis—Tamoxifen—pancreatic cancer	0.000805	0.00173	CcSEcCtD
Alfuzosin—Vomiting—Erlotinib—pancreatic cancer	0.000804	0.00172	CcSEcCtD
Alfuzosin—Somnolence—Irinotecan—pancreatic cancer	0.000802	0.00172	CcSEcCtD
Alfuzosin—Headache—Tamoxifen—pancreatic cancer	0.000801	0.00172	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.0008	0.00172	CcSEcCtD
Alfuzosin—Rash—Erlotinib—pancreatic cancer	0.000797	0.00171	CcSEcCtD
Alfuzosin—Dermatitis—Erlotinib—pancreatic cancer	0.000797	0.00171	CcSEcCtD
Alfuzosin—Angiopathy—Docetaxel—pancreatic cancer	0.000796	0.00171	CcSEcCtD
Alfuzosin—Dyspepsia—Irinotecan—pancreatic cancer	0.000794	0.0017	CcSEcCtD
Alfuzosin—Headache—Erlotinib—pancreatic cancer	0.000792	0.0017	CcSEcCtD
Alfuzosin—Osteoarthritis—Doxorubicin—pancreatic cancer	0.000792	0.0017	CcSEcCtD
Alfuzosin—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000791	0.0017	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000787	0.00169	CcSEcCtD
Alfuzosin—Asthenia—Sunitinib—pancreatic cancer	0.000786	0.00168	CcSEcCtD
Alfuzosin—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.000781	0.00168	CcSEcCtD
Alfuzosin—Abdominal pain upper—Epirubicin—pancreatic cancer	0.000781	0.00168	CcSEcCtD
Alfuzosin—Somnolence—Gemcitabine—pancreatic cancer	0.000781	0.00167	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000779	0.00167	CcSEcCtD
Alfuzosin—Fatigue—Irinotecan—pancreatic cancer	0.000778	0.00167	CcSEcCtD
Alfuzosin—Pruritus—Sunitinib—pancreatic cancer	0.000775	0.00166	CcSEcCtD
Alfuzosin—Breast disorder—Epirubicin—pancreatic cancer	0.000773	0.00166	CcSEcCtD
Alfuzosin—Pain—Irinotecan—pancreatic cancer	0.000771	0.00165	CcSEcCtD
Alfuzosin—Constipation—Irinotecan—pancreatic cancer	0.000771	0.00165	CcSEcCtD
Alfuzosin—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.00077	0.00165	CcSEcCtD
Alfuzosin—Mental disorder—Docetaxel—pancreatic cancer	0.000769	0.00165	CcSEcCtD
Alfuzosin—Somnolence—Fluorouracil—pancreatic cancer	0.000768	0.00165	CcSEcCtD
Alfuzosin—Dyspepsia—Fluorouracil—pancreatic cancer	0.00076	0.00163	CcSEcCtD
Alfuzosin—Nausea—Tamoxifen—pancreatic cancer	0.000759	0.00163	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000758	0.00163	CcSEcCtD
Alfuzosin—Fatigue—Gemcitabine—pancreatic cancer	0.000757	0.00162	CcSEcCtD
Alfuzosin—Pain—Gemcitabine—pancreatic cancer	0.000751	0.00161	CcSEcCtD
Alfuzosin—Constipation—Gemcitabine—pancreatic cancer	0.000751	0.00161	CcSEcCtD
Alfuzosin—Nausea—Erlotinib—pancreatic cancer	0.000751	0.00161	CcSEcCtD
Alfuzosin—Diarrhoea—Sunitinib—pancreatic cancer	0.000749	0.00161	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000746	0.0016	CcSEcCtD
Alfuzosin—Feeling abnormal—Irinotecan—pancreatic cancer	0.000743	0.00159	CcSEcCtD
Alfuzosin—Back pain—Docetaxel—pancreatic cancer	0.000739	0.00158	CcSEcCtD
Alfuzosin—Pain—Fluorouracil—pancreatic cancer	0.000739	0.00158	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000738	0.00158	CcSEcCtD
Alfuzosin—Dizziness—Sunitinib—pancreatic cancer	0.000724	0.00155	CcSEcCtD
Alfuzosin—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000724	0.00155	CcSEcCtD
Alfuzosin—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000723	0.00155	CcSEcCtD
Alfuzosin—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.000723	0.00155	CcSEcCtD
Alfuzosin—Angina pectoris—Epirubicin—pancreatic cancer	0.00072	0.00154	CcSEcCtD
Alfuzosin—Breast disorder—Doxorubicin—pancreatic cancer	0.000715	0.00153	CcSEcCtD
Alfuzosin—Abdominal pain—Irinotecan—pancreatic cancer	0.000713	0.00153	CcSEcCtD
Alfuzosin—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000713	0.00153	CcSEcCtD
Alfuzosin—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000712	0.00153	CcSEcCtD
Alfuzosin—Bronchitis—Epirubicin—pancreatic cancer	0.000711	0.00152	CcSEcCtD
Alfuzosin—Vomiting—Sunitinib—pancreatic cancer	0.000696	0.00149	CcSEcCtD
Alfuzosin—Rash—Sunitinib—pancreatic cancer	0.00069	0.00148	CcSEcCtD
Alfuzosin—Dermatitis—Sunitinib—pancreatic cancer	0.00069	0.00148	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000687	0.00147	CcSEcCtD
Alfuzosin—Urticaria—Fluorouracil—pancreatic cancer	0.000686	0.00147	CcSEcCtD
Alfuzosin—Headache—Sunitinib—pancreatic cancer	0.000686	0.00147	CcSEcCtD
Alfuzosin—Syncope—Docetaxel—pancreatic cancer	0.000685	0.00147	CcSEcCtD
Alfuzosin—Palpitations—Docetaxel—pancreatic cancer	0.000675	0.00145	CcSEcCtD
Alfuzosin—Loss of consciousness—Docetaxel—pancreatic cancer	0.000671	0.00144	CcSEcCtD
Alfuzosin—Angina pectoris—Doxorubicin—pancreatic cancer	0.000667	0.00143	CcSEcCtD
Alfuzosin—Drowsiness—Epirubicin—pancreatic cancer	0.000659	0.00141	CcSEcCtD
Alfuzosin—Infestation NOS—Epirubicin—pancreatic cancer	0.000659	0.00141	CcSEcCtD
Alfuzosin—Infestation—Epirubicin—pancreatic cancer	0.000659	0.00141	CcSEcCtD
Alfuzosin—Bronchitis—Doxorubicin—pancreatic cancer	0.000658	0.00141	CcSEcCtD
Alfuzosin—Arthralgia—Docetaxel—pancreatic cancer	0.00065	0.00139	CcSEcCtD
Alfuzosin—Chest pain—Docetaxel—pancreatic cancer	0.00065	0.00139	CcSEcCtD
Alfuzosin—Nausea—Sunitinib—pancreatic cancer	0.00065	0.00139	CcSEcCtD
Alfuzosin—Asthenia—Irinotecan—pancreatic cancer	0.000647	0.00139	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000646	0.00139	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000646	0.00138	CcSEcCtD
Alfuzosin—Jaundice—Epirubicin—pancreatic cancer	0.000643	0.00138	CcSEcCtD
Alfuzosin—Dry mouth—Docetaxel—pancreatic cancer	0.000636	0.00136	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000636	0.00136	CcSEcCtD
Alfuzosin—Sweating—Epirubicin—pancreatic cancer	0.000632	0.00136	CcSEcCtD
Alfuzosin—Asthenia—Gemcitabine—pancreatic cancer	0.00063	0.00135	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000624	0.00134	CcSEcCtD
Alfuzosin—Oedema—Docetaxel—pancreatic cancer	0.000623	0.00134	CcSEcCtD
Alfuzosin—Pruritus—Gemcitabine—pancreatic cancer	0.000622	0.00133	CcSEcCtD
Alfuzosin—Infection—Docetaxel—pancreatic cancer	0.000619	0.00133	CcSEcCtD
Alfuzosin—Sinusitis—Epirubicin—pancreatic cancer	0.000619	0.00133	CcSEcCtD
Alfuzosin—Diarrhoea—Irinotecan—pancreatic cancer	0.000617	0.00132	CcSEcCtD
Alfuzosin—Shock—Docetaxel—pancreatic cancer	0.000613	0.00131	CcSEcCtD
Alfuzosin—Nervous system disorder—Docetaxel—pancreatic cancer	0.000611	0.00131	CcSEcCtD
Alfuzosin—Pruritus—Fluorouracil—pancreatic cancer	0.000611	0.00131	CcSEcCtD
Alfuzosin—Thrombocytopenia—Docetaxel—pancreatic cancer	0.00061	0.00131	CcSEcCtD
Alfuzosin—Infestation NOS—Doxorubicin—pancreatic cancer	0.00061	0.00131	CcSEcCtD
Alfuzosin—Infestation—Doxorubicin—pancreatic cancer	0.00061	0.00131	CcSEcCtD
Alfuzosin—Drowsiness—Doxorubicin—pancreatic cancer	0.00061	0.00131	CcSEcCtD
Alfuzosin—Tachycardia—Docetaxel—pancreatic cancer	0.000608	0.0013	CcSEcCtD
Alfuzosin—Skin disorder—Docetaxel—pancreatic cancer	0.000606	0.0013	CcSEcCtD
Alfuzosin—Diarrhoea—Gemcitabine—pancreatic cancer	0.000601	0.00129	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000598	0.00128	CcSEcCtD
Alfuzosin—Dizziness—Irinotecan—pancreatic cancer	0.000596	0.00128	CcSEcCtD
Alfuzosin—Jaundice—Doxorubicin—pancreatic cancer	0.000595	0.00127	CcSEcCtD
Alfuzosin—Rhinitis—Epirubicin—pancreatic cancer	0.000593	0.00127	CcSEcCtD
Alfuzosin—Diarrhoea—Fluorouracil—pancreatic cancer	0.000591	0.00127	CcSEcCtD
Alfuzosin—Pharyngitis—Epirubicin—pancreatic cancer	0.000587	0.00126	CcSEcCtD
Alfuzosin—Sweating—Doxorubicin—pancreatic cancer	0.000585	0.00125	CcSEcCtD
Alfuzosin—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000585	0.00125	CcSEcCtD
Alfuzosin—Hypotension—Docetaxel—pancreatic cancer	0.000583	0.00125	CcSEcCtD
Alfuzosin—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000582	0.00125	CcSEcCtD
Alfuzosin—Urethral disorder—Epirubicin—pancreatic cancer	0.00058	0.00124	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000577	0.00124	CcSEcCtD
Alfuzosin—Vomiting—Irinotecan—pancreatic cancer	0.000573	0.00123	CcSEcCtD
Alfuzosin—Sinusitis—Doxorubicin—pancreatic cancer	0.000572	0.00123	CcSEcCtD
Alfuzosin—Dizziness—Fluorouracil—pancreatic cancer	0.000571	0.00122	CcSEcCtD
Alfuzosin—Rash—Irinotecan—pancreatic cancer	0.000569	0.00122	CcSEcCtD
Alfuzosin—Dermatitis—Irinotecan—pancreatic cancer	0.000568	0.00122	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000568	0.00122	CcSEcCtD
Alfuzosin—Headache—Irinotecan—pancreatic cancer	0.000565	0.00121	CcSEcCtD
Alfuzosin—Vomiting—Gemcitabine—pancreatic cancer	0.000559	0.0012	CcSEcCtD
Alfuzosin—Somnolence—Docetaxel—pancreatic cancer	0.000554	0.00119	CcSEcCtD
Alfuzosin—Rash—Gemcitabine—pancreatic cancer	0.000554	0.00119	CcSEcCtD
Alfuzosin—Dermatitis—Gemcitabine—pancreatic cancer	0.000553	0.00119	CcSEcCtD
Alfuzosin—Eye disorder—Epirubicin—pancreatic cancer	0.000553	0.00119	CcSEcCtD
Alfuzosin—Headache—Gemcitabine—pancreatic cancer	0.00055	0.00118	CcSEcCtD
Alfuzosin—Flushing—Epirubicin—pancreatic cancer	0.000549	0.00118	CcSEcCtD
Alfuzosin—Cardiac disorder—Epirubicin—pancreatic cancer	0.000549	0.00118	CcSEcCtD
Alfuzosin—Vomiting—Fluorouracil—pancreatic cancer	0.000549	0.00118	CcSEcCtD
Alfuzosin—Rhinitis—Doxorubicin—pancreatic cancer	0.000549	0.00118	CcSEcCtD
Alfuzosin—Dyspepsia—Docetaxel—pancreatic cancer	0.000549	0.00118	CcSEcCtD
Alfuzosin—Rash—Fluorouracil—pancreatic cancer	0.000545	0.00117	CcSEcCtD
Alfuzosin—Dermatitis—Fluorouracil—pancreatic cancer	0.000544	0.00117	CcSEcCtD
Alfuzosin—Pharyngitis—Doxorubicin—pancreatic cancer	0.000544	0.00117	CcSEcCtD
Alfuzosin—Headache—Fluorouracil—pancreatic cancer	0.000541	0.00116	CcSEcCtD
Alfuzosin—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000541	0.00116	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000538	0.00115	CcSEcCtD
Alfuzosin—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000538	0.00115	CcSEcCtD
Alfuzosin—Fatigue—Docetaxel—pancreatic cancer	0.000538	0.00115	CcSEcCtD
Alfuzosin—Angiopathy—Epirubicin—pancreatic cancer	0.000537	0.00115	CcSEcCtD
Alfuzosin—Urethral disorder—Doxorubicin—pancreatic cancer	0.000537	0.00115	CcSEcCtD
Alfuzosin—Nausea—Irinotecan—pancreatic cancer	0.000536	0.00115	CcSEcCtD
Alfuzosin—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000533	0.00114	CcSEcCtD
Alfuzosin—Pain—Docetaxel—pancreatic cancer	0.000533	0.00114	CcSEcCtD
Alfuzosin—Constipation—Docetaxel—pancreatic cancer	0.000533	0.00114	CcSEcCtD
Alfuzosin—Nausea—Gemcitabine—pancreatic cancer	0.000522	0.00112	CcSEcCtD
Alfuzosin—Mental disorder—Epirubicin—pancreatic cancer	0.000519	0.00111	CcSEcCtD
Alfuzosin—Feeling abnormal—Docetaxel—pancreatic cancer	0.000514	0.0011	CcSEcCtD
Alfuzosin—Nausea—Fluorouracil—pancreatic cancer	0.000513	0.0011	CcSEcCtD
Alfuzosin—Eye disorder—Doxorubicin—pancreatic cancer	0.000512	0.0011	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00051	0.00109	CcSEcCtD
Alfuzosin—Flushing—Doxorubicin—pancreatic cancer	0.000508	0.00109	CcSEcCtD
Alfuzosin—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000508	0.00109	CcSEcCtD
Alfuzosin—Back pain—Epirubicin—pancreatic cancer	0.000498	0.00107	CcSEcCtD
Alfuzosin—Angiopathy—Doxorubicin—pancreatic cancer	0.000497	0.00107	CcSEcCtD
Alfuzosin—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000494	0.00106	CcSEcCtD
Alfuzosin—Abdominal pain—Docetaxel—pancreatic cancer	0.000493	0.00106	CcSEcCtD
Alfuzosin—Mental disorder—Doxorubicin—pancreatic cancer	0.00048	0.00103	CcSEcCtD
Alfuzosin—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000478	0.00102	CcSEcCtD
Alfuzosin—Malaise—Epirubicin—pancreatic cancer	0.000465	0.000996	CcSEcCtD
Alfuzosin—Vertigo—Epirubicin—pancreatic cancer	0.000463	0.000992	CcSEcCtD
Alfuzosin—Syncope—Epirubicin—pancreatic cancer	0.000462	0.000991	CcSEcCtD
Alfuzosin—Back pain—Doxorubicin—pancreatic cancer	0.000461	0.000989	CcSEcCtD
Alfuzosin—Palpitations—Epirubicin—pancreatic cancer	0.000455	0.000976	CcSEcCtD
Alfuzosin—Loss of consciousness—Epirubicin—pancreatic cancer	0.000453	0.000971	CcSEcCtD
Alfuzosin—Asthenia—Docetaxel—pancreatic cancer	0.000447	0.000959	CcSEcCtD
Alfuzosin—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000442	0.000948	CcSEcCtD
Alfuzosin—Pruritus—Docetaxel—pancreatic cancer	0.000441	0.000946	CcSEcCtD
Alfuzosin—Arthralgia—Epirubicin—pancreatic cancer	0.000439	0.00094	CcSEcCtD
Alfuzosin—Chest pain—Epirubicin—pancreatic cancer	0.000439	0.00094	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000436	0.000934	CcSEcCtD
Alfuzosin—Discomfort—Epirubicin—pancreatic cancer	0.000433	0.000929	CcSEcCtD
Alfuzosin—Malaise—Doxorubicin—pancreatic cancer	0.00043	0.000922	CcSEcCtD
Alfuzosin—Dry mouth—Epirubicin—pancreatic cancer	0.000429	0.00092	CcSEcCtD
Alfuzosin—Vertigo—Doxorubicin—pancreatic cancer	0.000428	0.000918	CcSEcCtD
Alfuzosin—Syncope—Doxorubicin—pancreatic cancer	0.000428	0.000917	CcSEcCtD
Alfuzosin—Diarrhoea—Docetaxel—pancreatic cancer	0.000427	0.000914	CcSEcCtD
Alfuzosin—Palpitations—Doxorubicin—pancreatic cancer	0.000421	0.000903	CcSEcCtD
Alfuzosin—Oedema—Epirubicin—pancreatic cancer	0.000421	0.000902	CcSEcCtD
Alfuzosin—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000419	0.000898	CcSEcCtD
Alfuzosin—Infection—Epirubicin—pancreatic cancer	0.000418	0.000896	CcSEcCtD
Alfuzosin—Shock—Epirubicin—pancreatic cancer	0.000414	0.000887	CcSEcCtD
Alfuzosin—Nervous system disorder—Epirubicin—pancreatic cancer	0.000412	0.000884	CcSEcCtD
Alfuzosin—Dizziness—Docetaxel—pancreatic cancer	0.000412	0.000884	CcSEcCtD
Alfuzosin—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000412	0.000883	CcSEcCtD
Alfuzosin—Tachycardia—Epirubicin—pancreatic cancer	0.00041	0.00088	CcSEcCtD
Alfuzosin—Skin disorder—Epirubicin—pancreatic cancer	0.000408	0.000876	CcSEcCtD
Alfuzosin—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000407	0.000872	CcSEcCtD
Alfuzosin—Arthralgia—Doxorubicin—pancreatic cancer	0.000406	0.00087	CcSEcCtD
Alfuzosin—Chest pain—Doxorubicin—pancreatic cancer	0.000406	0.00087	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000403	0.000864	CcSEcCtD
Alfuzosin—Discomfort—Doxorubicin—pancreatic cancer	0.000401	0.00086	CcSEcCtD
Alfuzosin—Dry mouth—Doxorubicin—pancreatic cancer	0.000397	0.000851	CcSEcCtD
Alfuzosin—Vomiting—Docetaxel—pancreatic cancer	0.000396	0.00085	CcSEcCtD
Alfuzosin—Rash—Docetaxel—pancreatic cancer	0.000393	0.000843	CcSEcCtD
Alfuzosin—Hypotension—Epirubicin—pancreatic cancer	0.000393	0.000842	CcSEcCtD
Alfuzosin—Dermatitis—Docetaxel—pancreatic cancer	0.000393	0.000842	CcSEcCtD
Alfuzosin—Headache—Docetaxel—pancreatic cancer	0.000391	0.000837	CcSEcCtD
Alfuzosin—Oedema—Doxorubicin—pancreatic cancer	0.000389	0.000834	CcSEcCtD
Alfuzosin—Infection—Doxorubicin—pancreatic cancer	0.000387	0.000829	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000383	0.000821	CcSEcCtD
Alfuzosin—Shock—Doxorubicin—pancreatic cancer	0.000383	0.000821	CcSEcCtD
Alfuzosin—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000382	0.000818	CcSEcCtD
Alfuzosin—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000381	0.000817	CcSEcCtD
Alfuzosin—Tachycardia—Doxorubicin—pancreatic cancer	0.00038	0.000814	CcSEcCtD
Alfuzosin—Skin disorder—Doxorubicin—pancreatic cancer	0.000378	0.00081	CcSEcCtD
Alfuzosin—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000376	0.000806	CcSEcCtD
Alfuzosin—Somnolence—Epirubicin—pancreatic cancer	0.000374	0.000801	CcSEcCtD
Alfuzosin—Nausea—Docetaxel—pancreatic cancer	0.00037	0.000794	CcSEcCtD
Alfuzosin—Dyspepsia—Epirubicin—pancreatic cancer	0.00037	0.000794	CcSEcCtD
Alfuzosin—Hypotension—Doxorubicin—pancreatic cancer	0.000364	0.000779	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000363	0.000778	CcSEcCtD
Alfuzosin—Fatigue—Epirubicin—pancreatic cancer	0.000363	0.000777	CcSEcCtD
Alfuzosin—Constipation—Epirubicin—pancreatic cancer	0.00036	0.000771	CcSEcCtD
Alfuzosin—Pain—Epirubicin—pancreatic cancer	0.00036	0.000771	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000355	0.00076	CcSEcCtD
Alfuzosin—Feeling abnormal—Epirubicin—pancreatic cancer	0.000347	0.000743	CcSEcCtD
Alfuzosin—Somnolence—Doxorubicin—pancreatic cancer	0.000346	0.000742	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000344	0.000737	CcSEcCtD
Alfuzosin—Dyspepsia—Doxorubicin—pancreatic cancer	0.000343	0.000734	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000336	0.00072	CcSEcCtD
Alfuzosin—Fatigue—Doxorubicin—pancreatic cancer	0.000335	0.000719	CcSEcCtD
Alfuzosin—Urticaria—Epirubicin—pancreatic cancer	0.000334	0.000716	CcSEcCtD
Alfuzosin—Pain—Doxorubicin—pancreatic cancer	0.000333	0.000713	CcSEcCtD
Alfuzosin—Constipation—Doxorubicin—pancreatic cancer	0.000333	0.000713	CcSEcCtD
Alfuzosin—Abdominal pain—Epirubicin—pancreatic cancer	0.000332	0.000713	CcSEcCtD
Alfuzosin—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000321	0.000687	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000318	0.000682	CcSEcCtD
Alfuzosin—Urticaria—Doxorubicin—pancreatic cancer	0.000309	0.000663	CcSEcCtD
Alfuzosin—Abdominal pain—Doxorubicin—pancreatic cancer	0.000308	0.000659	CcSEcCtD
Alfuzosin—Asthenia—Epirubicin—pancreatic cancer	0.000302	0.000647	CcSEcCtD
Alfuzosin—Pruritus—Epirubicin—pancreatic cancer	0.000298	0.000638	CcSEcCtD
Alfuzosin—Diarrhoea—Epirubicin—pancreatic cancer	0.000288	0.000617	CcSEcCtD
Alfuzosin—Asthenia—Doxorubicin—pancreatic cancer	0.000279	0.000598	CcSEcCtD
Alfuzosin—Dizziness—Epirubicin—pancreatic cancer	0.000278	0.000596	CcSEcCtD
Alfuzosin—Pruritus—Doxorubicin—pancreatic cancer	0.000275	0.00059	CcSEcCtD
Alfuzosin—Vomiting—Epirubicin—pancreatic cancer	0.000267	0.000573	CcSEcCtD
Alfuzosin—Diarrhoea—Doxorubicin—pancreatic cancer	0.000266	0.000571	CcSEcCtD
Alfuzosin—Rash—Epirubicin—pancreatic cancer	0.000265	0.000568	CcSEcCtD
Alfuzosin—Dermatitis—Epirubicin—pancreatic cancer	0.000265	0.000568	CcSEcCtD
Alfuzosin—Headache—Epirubicin—pancreatic cancer	0.000263	0.000565	CcSEcCtD
Alfuzosin—Dizziness—Doxorubicin—pancreatic cancer	0.000257	0.000552	CcSEcCtD
Alfuzosin—Nausea—Epirubicin—pancreatic cancer	0.00025	0.000535	CcSEcCtD
Alfuzosin—Vomiting—Doxorubicin—pancreatic cancer	0.000247	0.00053	CcSEcCtD
Alfuzosin—Rash—Doxorubicin—pancreatic cancer	0.000245	0.000526	CcSEcCtD
Alfuzosin—Dermatitis—Doxorubicin—pancreatic cancer	0.000245	0.000525	CcSEcCtD
Alfuzosin—Headache—Doxorubicin—pancreatic cancer	0.000244	0.000523	CcSEcCtD
Alfuzosin—Nausea—Doxorubicin—pancreatic cancer	0.000231	0.000495	CcSEcCtD
Alfuzosin—ADRA1B—Signaling by GPCR—CNR1—pancreatic cancer	9.17e-05	0.000743	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—SSTR2—pancreatic cancer	9.16e-05	0.000742	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PPP2R5B—pancreatic cancer	9.11e-05	0.000738	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NRP1—pancreatic cancer	9.11e-05	0.000738	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CNR2—pancreatic cancer	9.09e-05	0.000737	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—GLP1R—pancreatic cancer	9.09e-05	0.000737	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR ligand binding—CXCL8—pancreatic cancer	9.09e-05	0.000736	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—CNR1—pancreatic cancer	8.97e-05	0.000727	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CCKAR—pancreatic cancer	8.95e-05	0.000725	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—GCG—pancreatic cancer	8.86e-05	0.000717	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CCKBR—pancreatic cancer	8.85e-05	0.000717	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—SST—pancreatic cancer	8.83e-05	0.000715	CbGpPWpGaD
Alfuzosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	8.8e-05	0.000713	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—HEY2—pancreatic cancer	8.77e-05	0.00071	CbGpPWpGaD
Alfuzosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pancreatic cancer	8.68e-05	0.000704	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—JAG2—pancreatic cancer	8.68e-05	0.000703	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—GCG—pancreatic cancer	8.66e-05	0.000702	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—GAST—pancreatic cancer	8.56e-05	0.000694	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MEN1—pancreatic cancer	8.55e-05	0.000693	CbGpPWpGaD
Alfuzosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	8.49e-05	0.000687	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—AGTR1—pancreatic cancer	8.45e-05	0.000684	CbGpPWpGaD
Alfuzosin—ADRA1A—G alpha (q) signalling events—PIK3CA—pancreatic cancer	8.43e-05	0.000683	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—GLI1—pancreatic cancer	8.32e-05	0.000674	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—DTX4—pancreatic cancer	8.32e-05	0.000674	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—AGTR1—pancreatic cancer	8.26e-05	0.000669	CbGpPWpGaD
Alfuzosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	8.2e-05	0.000665	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—SHH—pancreatic cancer	8.16e-05	0.000661	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—CNR1—pancreatic cancer	8.14e-05	0.00066	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—SCT—pancreatic cancer	8.12e-05	0.000658	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—HEY1—pancreatic cancer	8.12e-05	0.000658	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—NOTCH4—pancreatic cancer	8.11e-05	0.000657	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NRP1—pancreatic cancer	8.09e-05	0.000655	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PPP2R5B—pancreatic cancer	8.09e-05	0.000655	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—IAPP—pancreatic cancer	8.05e-05	0.000653	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—GCG—pancreatic cancer	7.87e-05	0.000637	CbGpPWpGaD
Alfuzosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	7.85e-05	0.000636	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—HEY2—pancreatic cancer	7.79e-05	0.000631	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CCK—pancreatic cancer	7.74e-05	0.000627	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PTHLH—pancreatic cancer	7.73e-05	0.000626	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PTCH1—pancreatic cancer	7.73e-05	0.000626	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—GAST—pancreatic cancer	7.61e-05	0.000616	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CNR2—pancreatic cancer	7.55e-05	0.000611	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—GLP1R—pancreatic cancer	7.55e-05	0.000611	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—CXCL8—pancreatic cancer	7.54e-05	0.000611	CbGpPWpGaD
Alfuzosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	7.54e-05	0.000611	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—AGTR1—pancreatic cancer	7.5e-05	0.000608	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CCKAR—pancreatic cancer	7.43e-05	0.000602	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—SCT—pancreatic cancer	7.21e-05	0.000584	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—HEY1—pancreatic cancer	7.21e-05	0.000584	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—JAG2—pancreatic cancer	7.2e-05	0.000583	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MEN1—pancreatic cancer	7.1e-05	0.000575	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—SST—pancreatic cancer	7.07e-05	0.000573	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—PIK3CG—pancreatic cancer	6.97e-05	0.000565	CbGpPWpGaD
Alfuzosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	6.97e-05	0.000565	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—JAG1—pancreatic cancer	6.92e-05	0.000561	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—NOTCH3—pancreatic cancer	6.89e-05	0.000558	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CCK—pancreatic cancer	6.88e-05	0.000557	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—SHH—pancreatic cancer	6.77e-05	0.000548	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NOTCH4—pancreatic cancer	6.73e-05	0.000545	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CNR2—pancreatic cancer	6.7e-05	0.000543	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—GLP1R—pancreatic cancer	6.7e-05	0.000543	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—CXCL8—pancreatic cancer	6.7e-05	0.000543	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—IAPP—pancreatic cancer	6.69e-05	0.000542	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CCKAR—pancreatic cancer	6.6e-05	0.000534	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CNR1—pancreatic cancer	6.53e-05	0.000529	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PTHLH—pancreatic cancer	6.42e-05	0.00052	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PTCH1—pancreatic cancer	6.42e-05	0.00052	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—JAG2—pancreatic cancer	6.4e-05	0.000518	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—PIK3CG—pancreatic cancer	6.33e-05	0.000513	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—GCG—pancreatic cancer	6.3e-05	0.000511	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MEN1—pancreatic cancer	6.3e-05	0.000511	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—PIK3CD—pancreatic cancer	6.13e-05	0.000497	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—AGTR1—pancreatic cancer	6.01e-05	0.000487	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—SHH—pancreatic cancer	6.01e-05	0.000487	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NOTCH4—pancreatic cancer	5.98e-05	0.000484	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—IAPP—pancreatic cancer	5.94e-05	0.000481	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—STK11—pancreatic cancer	5.93e-05	0.00048	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—SST—pancreatic cancer	5.87e-05	0.000476	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—PIK3CG—pancreatic cancer	5.79e-05	0.000469	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—JAG1—pancreatic cancer	5.74e-05	0.000465	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NOTCH3—pancreatic cancer	5.72e-05	0.000463	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PTHLH—pancreatic cancer	5.7e-05	0.000462	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PTCH1—pancreatic cancer	5.7e-05	0.000462	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—PIK3CD—pancreatic cancer	5.57e-05	0.000451	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CNR1—pancreatic cancer	5.42e-05	0.000439	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—PIK3CB—pancreatic cancer	5.34e-05	0.000433	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—PIK3CG—pancreatic cancer	5.26e-05	0.000426	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—GCG—pancreatic cancer	5.23e-05	0.000424	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—SST—pancreatic cancer	5.21e-05	0.000422	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PRSS1—pancreatic cancer	5.2e-05	0.000421	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—SMAD4—pancreatic cancer	5.19e-05	0.000421	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—PIK3CG—pancreatic cancer	5.14e-05	0.000417	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—CXCL8—pancreatic cancer	5.14e-05	0.000416	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—JAG1—pancreatic cancer	5.1e-05	0.000413	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—PIK3CD—pancreatic cancer	5.09e-05	0.000412	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NOTCH3—pancreatic cancer	5.08e-05	0.000412	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—HES1—pancreatic cancer	5.07e-05	0.000411	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—AGTR1—pancreatic cancer	4.99e-05	0.000404	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—STK11—pancreatic cancer	4.92e-05	0.000398	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—PIK3CB—pancreatic cancer	4.85e-05	0.000393	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CNR1—pancreatic cancer	4.81e-05	0.00039	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—PIK3CG—pancreatic cancer	4.67e-05	0.000378	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—CXCL8—pancreatic cancer	4.66e-05	0.000378	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—GCG—pancreatic cancer	4.65e-05	0.000376	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—PIK3CD—pancreatic cancer	4.62e-05	0.000374	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—PIK3CD—pancreatic cancer	4.52e-05	0.000366	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ARG2—pancreatic cancer	4.5e-05	0.000365	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—TERT—pancreatic cancer	4.44e-05	0.00036	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—PIK3CB—pancreatic cancer	4.44e-05	0.000359	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—AGTR1—pancreatic cancer	4.43e-05	0.000359	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—STK11—pancreatic cancer	4.37e-05	0.000354	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—SMAD4—pancreatic cancer	4.31e-05	0.000349	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—CXCL8—pancreatic cancer	4.26e-05	0.000345	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—HIF1A—pancreatic cancer	4.25e-05	0.000344	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—TSC2—pancreatic cancer	4.24e-05	0.000343	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—HES1—pancreatic cancer	4.21e-05	0.000341	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—APOE—pancreatic cancer	4.15e-05	0.000336	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—PIK3CD—pancreatic cancer	4.1e-05	0.000333	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—KDR—pancreatic cancer	4.06e-05	0.000329	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—PIK3CB—pancreatic cancer	4.03e-05	0.000326	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—PIK3CB—pancreatic cancer	3.94e-05	0.000319	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—TYMP—pancreatic cancer	3.94e-05	0.000319	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—CXCL8—pancreatic cancer	3.87e-05	0.000314	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—NFKBIA—pancreatic cancer	3.86e-05	0.000313	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—SMAD4—pancreatic cancer	3.83e-05	0.00031	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—NOTCH1—pancreatic cancer	3.83e-05	0.00031	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—CXCL8—pancreatic cancer	3.79e-05	0.000307	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PIK3CG—pancreatic cancer	3.74e-05	0.000303	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—NRAS—pancreatic cancer	3.74e-05	0.000303	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—HES1—pancreatic cancer	3.74e-05	0.000303	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—EGF—pancreatic cancer	3.7e-05	0.0003	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—TERT—pancreatic cancer	3.69e-05	0.000299	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—PIK3CB—pancreatic cancer	3.58e-05	0.00029	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—HIF1A—pancreatic cancer	3.52e-05	0.000286	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—TSC2—pancreatic cancer	3.52e-05	0.000285	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—APOE—pancreatic cancer	3.44e-05	0.000279	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—CXCL8—pancreatic cancer	3.44e-05	0.000279	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—EGFR—pancreatic cancer	3.41e-05	0.000276	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—KDR—pancreatic cancer	3.37e-05	0.000273	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PIK3CD—pancreatic cancer	3.29e-05	0.000266	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—TERT—pancreatic cancer	3.27e-05	0.000265	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—PIK3CA—pancreatic cancer	3.26e-05	0.000264	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—KRAS—pancreatic cancer	3.22e-05	0.000261	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NFKBIA—pancreatic cancer	3.21e-05	0.00026	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NOTCH1—pancreatic cancer	3.18e-05	0.000257	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GLP1R—pancreatic cancer	3.17e-05	0.000257	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—HIF1A—pancreatic cancer	3.13e-05	0.000254	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—TSC2—pancreatic cancer	3.12e-05	0.000253	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—DPYD—pancreatic cancer	3.12e-05	0.000253	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PIK3CG—pancreatic cancer	3.11e-05	0.000252	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—NRAS—pancreatic cancer	3.11e-05	0.000252	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—EGF—pancreatic cancer	3.07e-05	0.000249	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—APOE—pancreatic cancer	3.06e-05	0.000248	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—KDR—pancreatic cancer	2.99e-05	0.000243	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	2.96e-05	0.00024	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—PIK3CA—pancreatic cancer	2.96e-05	0.00024	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PIK3CB—pancreatic cancer	2.87e-05	0.000232	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NFKBIA—pancreatic cancer	2.85e-05	0.000231	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—EGFR—pancreatic cancer	2.83e-05	0.000229	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NOTCH1—pancreatic cancer	2.82e-05	0.000229	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PIK3CG—pancreatic cancer	2.76e-05	0.000223	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—NRAS—pancreatic cancer	2.76e-05	0.000223	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CXCL8—pancreatic cancer	2.76e-05	0.000223	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—HRAS—pancreatic cancer	2.74e-05	0.000222	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PIK3CD—pancreatic cancer	2.73e-05	0.000221	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—EGF—pancreatic cancer	2.73e-05	0.000221	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.7e-05	0.000219	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—KRAS—pancreatic cancer	2.67e-05	0.000217	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—AKT1—pancreatic cancer	2.66e-05	0.000216	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CASP3—pancreatic cancer	2.64e-05	0.000214	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CCND1—pancreatic cancer	2.57e-05	0.000208	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CTNNB1—pancreatic cancer	2.54e-05	0.000206	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—EGFR—pancreatic cancer	2.51e-05	0.000204	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MMP9—pancreatic cancer	2.49e-05	0.000202	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PTEN—pancreatic cancer	2.48e-05	0.000201	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—PIK3CA—pancreatic cancer	2.46e-05	0.000199	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PIK3CD—pancreatic cancer	2.42e-05	0.000196	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—AKT1—pancreatic cancer	2.42e-05	0.000196	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.4e-05	0.000195	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PIK3CB—pancreatic cancer	2.38e-05	0.000193	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—KRAS—pancreatic cancer	2.37e-05	0.000192	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—SRC—pancreatic cancer	2.3e-05	0.000186	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CD44—pancreatic cancer	2.29e-05	0.000186	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CXCL8—pancreatic cancer	2.29e-05	0.000185	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—HRAS—pancreatic cancer	2.27e-05	0.000184	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—VEGFA—pancreatic cancer	2.24e-05	0.000181	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—STAT3—pancreatic cancer	2.22e-05	0.00018	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—NRAS—pancreatic cancer	2.21e-05	0.000179	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—AKT1—pancreatic cancer	2.21e-05	0.000179	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GCG—pancreatic cancer	2.2e-05	0.000178	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CASP3—pancreatic cancer	2.19e-05	0.000177	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—PIK3CA—pancreatic cancer	2.18e-05	0.000177	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CCND1—pancreatic cancer	2.13e-05	0.000173	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PIK3CB—pancreatic cancer	2.11e-05	0.000171	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CTNNB1—pancreatic cancer	2.11e-05	0.000171	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MMP9—pancreatic cancer	2.07e-05	0.000168	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—STK11—pancreatic cancer	2.07e-05	0.000168	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MYC—pancreatic cancer	2.06e-05	0.000167	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PTEN—pancreatic cancer	2.06e-05	0.000167	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—TGFB1—pancreatic cancer	2.05e-05	0.000166	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CXCL8—pancreatic cancer	2.03e-05	0.000165	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—HRAS—pancreatic cancer	2.02e-05	0.000163	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—EGFR—pancreatic cancer	2.01e-05	0.000163	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—AKT1—pancreatic cancer	2.01e-05	0.000163	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—AKT1—pancreatic cancer	1.96e-05	0.000159	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CASP3—pancreatic cancer	1.94e-05	0.000157	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—SRC—pancreatic cancer	1.91e-05	0.000154	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—KRAS—pancreatic cancer	1.9e-05	0.000154	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CCND1—pancreatic cancer	1.89e-05	0.000153	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CTNNB1—pancreatic cancer	1.87e-05	0.000152	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—VEGFA—pancreatic cancer	1.86e-05	0.00015	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—STAT3—pancreatic cancer	1.84e-05	0.000149	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MMP9—pancreatic cancer	1.84e-05	0.000149	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NRAS—pancreatic cancer	1.83e-05	0.000149	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PTEN—pancreatic cancer	1.83e-05	0.000148	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—AKT1—pancreatic cancer	1.78e-05	0.000144	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—TYMS—pancreatic cancer	1.78e-05	0.000144	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PIK3CA—pancreatic cancer	1.75e-05	0.000142	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MYC—pancreatic cancer	1.71e-05	0.000138	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—TGFB1—pancreatic cancer	1.7e-05	0.000138	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—SRC—pancreatic cancer	1.69e-05	0.000137	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—TP53—pancreatic cancer	1.69e-05	0.000137	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—EGFR—pancreatic cancer	1.67e-05	0.000135	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—VEGFA—pancreatic cancer	1.65e-05	0.000134	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—STAT3—pancreatic cancer	1.63e-05	0.000132	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NRAS—pancreatic cancer	1.63e-05	0.000132	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—HRAS—pancreatic cancer	1.62e-05	0.000131	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—KRAS—pancreatic cancer	1.58e-05	0.000128	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MYC—pancreatic cancer	1.52e-05	0.000123	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—TGFB1—pancreatic cancer	1.51e-05	0.000123	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—EGFR—pancreatic cancer	1.48e-05	0.00012	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PIK3CA—pancreatic cancer	1.45e-05	0.000118	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—APOE—pancreatic cancer	1.45e-05	0.000117	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—AKT1—pancreatic cancer	1.43e-05	0.000116	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—TP53—pancreatic cancer	1.4e-05	0.000114	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—KRAS—pancreatic cancer	1.4e-05	0.000114	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—HRAS—pancreatic cancer	1.34e-05	0.000109	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1.31e-05	0.000106	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PIK3CA—pancreatic cancer	1.29e-05	0.000104	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PPARG—pancreatic cancer	1.26e-05	0.000102	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—TP53—pancreatic cancer	1.25e-05	0.000101	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—HRAS—pancreatic cancer	1.19e-05	9.66e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—AKT1—pancreatic cancer	1.19e-05	9.6e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.15e-05	9.3e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—AKT1—pancreatic cancer	1.05e-05	8.53e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1e-05	8.11e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PTGS2—pancreatic cancer	9.91e-06	8.03e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PTEN—pancreatic cancer	8.65e-06	7e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	6.1e-06	4.94e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—AKT1—pancreatic cancer	4.98e-06	4.04e-05	CbGpPWpGaD
